Please use this identifier to cite or link to this item:
https://doi.org/10.1021/jm0503547
Title: | Structure-activity studies of peptides from the "hot-spot" region of human CD2 protein: Development of peptides for immunomodulation | Authors: | Liu, J. Ying, J. Chow, V.T.K. Hruby, V.J. Satyanarayanajois, S.D. |
Issue Date: | 6-Oct-2005 | Citation: | Liu, J., Ying, J., Chow, V.T.K., Hruby, V.J., Satyanarayanajois, S.D. (2005-10-06). Structure-activity studies of peptides from the "hot-spot" region of human CD2 protein: Development of peptides for immunomodulation. Journal of Medicinal Chemistry 48 (20) : 6236-6249. ScholarBank@NUS Repository. https://doi.org/10.1021/jm0503547 | Abstract: | CD2 is a cell surface protein belonging to the immunoglobulin superfamily (IgSF) that plays a key role in mediating adhesion between human T-lymphocytes and target cells. The interaction between cell-adhesion molecules CD2 and CD58 is critical for immune response. Modulation or inhibition of these interactions has been shown to be therapeutically useful. Synthetic 12-mer linear and cyclic peptides and cyclic hexapeptides from the β-turn and β-strand region (hot spot) of human CD2 protein were designed to modulate CD2-CD58 interaction. The 12-amino acid synthetic cyclic peptides effectively blocked the interaction between CD2 and CD58 proteins as demonstrated by E-rosetting and heterotypic adhesion assays. NMR and molecular modeling studies indicated that these cyclic peptides exhibit β-turn structure in solution and closely mimic the β-turn structure of the surface epitopes of CD2 protein. The designed cyclic peptides with β-turn structure have the ability to modulate CD2-CD58 interaction. © 2005 American Chemical Society. | Source Title: | Journal of Medicinal Chemistry | URI: | http://scholarbank.nus.edu.sg/handle/10635/106370 | ISSN: | 00222623 | DOI: | 10.1021/jm0503547 |
Appears in Collections: | Staff Publications |
Show full item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.